Repeated intrauterine exposures to inflammatory stimuli attenuated transforming growth factor-β signaling in the ovine fetal lung

Neonatology

Volumn 104, Issue 1, 2013, Pages 49-55

  Collins, Jennifer J P ^a   Kallapur, Suhas G ^b,c   Knox, Christine L ^d   Kemp, Matthew W ^c   Kuypers, Elke ^a   Zimmermann, Luc J I ^a   Newnham, John P ^c   Jobe, Alan H ^b,c   Kramer, Boris W ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF CINCINNATI   (United States)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

Bronchopulmonary dysplasia; Chorioamnionitis; Intrauterine infection; Lung development; Neonatal outcome

Indexed keywords

ELASTIN; LIPOPOLYSACCHARIDE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FETUS LUNG; INFLAMMATION; LUNG ALVEOLUS; LUNG DEVELOPMENT; LUNG DYSPLASIA; MALE; MERINO SHEEP; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UREAPLASMA PARVUM;

BACTERIA (MICROORGANISMS); OVIS; OVIS ARIES; UREAPLASMA PARVUM SEROVAR 3;

EID: 84878038355     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000350548     Document Type: Article

References (25)

1. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729.
2. Speer CP: Inflammation and bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 29-38.
3. DiGiulio DB, Romero R, Kusanovic JP, Gomez R, Kim CJ, Seok KS, Gotsch F, Mazaki-Tovi S, Vaisbuch E, Sanders K, Bik EM, Chaiworapongsa T, Oyarzun E, Relman DA: Prevalence and diversity of microbes in the amniotic fluid, the fetal inflammatory response, and pregnancy outcome in women with preterm pre-labor rupture of membranes. Am J Reprod Immunol 2010; 64: 38-57.
4. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, Kim KS: Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host response in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998; 179: 1254-1260.
5. Onderdonk AB, Delaney ML, DuBois AM, Allred EN, Leviton A: Detection of bacteria in placental tissues obtained from extremely low gestational age neonates. Am J Obstet Gynecol 2008; 198: 110.e1-e7.
6. Collins JJ, Kallapur SG, Knox CL, Nitsos I, Polglase GR, Pillow JJ, Kuypers E, Newnham JP, Jobe AH, Kramer BW: Inflammation in fetal sheep from intra-amniotic injection of Ureaplasma parvum . Am J Physiol Lung Cell Mol Physiol 2010; 299:L852-L860.
7. Novy MJ, Duffy L, Axthelm MK, Sadowsky DW, Witkin SS, Gravett MG, Cassell GH, Waites KB: Ureaplasma parvum or Mycoplasma hominis as sole pathogens cause chorioamnionitis, preterm delivery, and fetal pneumonia in rhesus macaques. Reprod Sci 2009; 16: 56-70.
8. Viscardi RM, Atamas SP, Luzina IG, Hasday JD, He JR, Sime PJ, Coalson JJ, Yoder BA: Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res 2006; 60: 141-146.
9. Kramer BW, Moss TJ, Willet KE, Newnham JP, Sly PD, Kallapur SG, Ikegami M, Jobe AH: Dose and time response after intra-amniotic endotoxin in preterm lambs. Am J Respir Crit Care Med 2001; 164: 982-988.
10. Kramer BW, Kallapur SG, Moss TJ, Nitsos I, Newnham JP, Jobe AH: Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep. Innate Immun 2009; 15: 101-107.
11. Kallapur SG, Kramer BW, Knox CL, Berry CA, Collins JJ, Kemp MW, Nitsos I, Polglase GR, Robinson J, Hillman NH, Newnham JP, Chougnet C, Jobe AH: Chronic fetal exposure to Ureaplasma parvum suppresses innate immune responses in sheep. J Immunol 2011; 187: 2688-2695.
12. Elgert KD: Immunology: Understanding the Immune System, ed 2. Hoboken/NJ, Wiley-Blackwell, 2009.
13. Shimizu T, Kida Y, Kuwano K: Ureaplasma parvum lipoproteins, including MB antigen, activate NF-κB through TLR1, TLR2 and TLR6. Microbiology 2008; 154: 1318-1325.
14. Bartram U, Speer CP: The role of transforming growth factor-β in lung development and disease. Chest 2004; 125: 754-765.
15. Kallapur SG, Jobe AH, Ball MK, Nitsos I, Moss TJ, Hillman NH, Newnham JP, Kramer BW: Pulmonary and systemic endotoxin tolerance in preterm fetal sheep exposed to chorioamnionitis. J Immunol 2007; 179: 8491-8499.
16. Burri PH: Structural aspects of postnatal lung development-alveolar formation and growth. Biol Neonate 2006; 89: 313-322.
17. Lee AJ, Lambermont VA, Pillow JJ, Polglase GR, Nitsos I, Newnham JP, Beilharz MW, Kallapur SG, Jobe AH, Kramer BW: Fetal responses to lipopolysaccharide-induced chorioamnionitis alter immune and airway responses in 7-week-old sheep. Am J Obstet Gynecol 2011; 204: 364 e317-e324.
18. Hartling L, Liang Y, Lacaze-Masmonteil T: Chorioamnionitis as a risk factor for bronchopulmonary dysplasia: A systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2012; 97:F8-F17.
19. Masterson JC, Molloy EL, Gilbert JL, McCormack N, Adams A, O'Dea S: Bone morphogenetic protein signalling in airway epithelial cells during regeneration. Cell Signal 2011; 23: 398-406.
20. Been JV, Debeer A, van Iwaarden JF, Kloosterboer N, Passos VL, Naulaers G, Zimmermann LJ: Early alterations of growth factor patterns in bronchoalveolar lavage fluid from preterm infants developing bronchopulmonary dysplasia. Pediatr Res 2010; 67: 83-89.
21. Ichiba H, Saito M, Yamano T: Amniotic fluid transforming growth factor-β1 and the risk for the development of neonatal bronchopulmonary dysplasia. Neonatology 2009; 96: 156-161.
22. Lahra MM, Beeby PJ, Jeffery HE: Intrauterine inflammation, neonatal sepsis, and chronic lung disease: a 13-year hospital cohort study. Pediatrics 2009; 123: 1314-1319.
23. Kramer BW, Joshi SN, Moss TJ, Newnham JP, Sindelar R, Jobe AH, Kallapur SG: Endotoxininduced maturation of monocytes in preterm fetal sheep lung. Am J Physiol Lung Cell Mol Physiol 2007; 293:L345-L353.
24. Azizia M, Lloyd J, Allen M, Klein N, Peebles D: Immune status in very preterm neonates. Pediatrics 2012; 129:e967-e974.
25. Van Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, Martin C: Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr 2002; 140: 171-176.